Imagery Rescripting as a Stand-alone Treatment for OCD and BDD. — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Imagery Rescripting as a Stand-alone Treatment for OCD and BDD. — Stella

Home/Obsessive-Compulsive Disorder/

View on ClinicalTrials.gov

Recruiting

Back to Obsessive-Compulsive Disorder trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

Netherlands

Department of Psychiatry, AMC, Amsterdam-Zuidoost, North Holland

Key details

Sponsor

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Enrollment target

~36 participants

Started

April 2023

Primary completion

January 2026

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

18 Years and older

Last updated April 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.